| High-Grade Serous Ovarian Cancer studied in …STUDIED_INderived28 of 28show fewer |
|---|
| → studied in | NCT05956093NA · active not recruiting 68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821879recruiting Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791732Phase 3 · not yet recruiting A Study of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab as Maintenance Therapy in Second-Line Platinum-Sensitive Recurrent Ovarian Cancer (REJOICE-Ovarian03) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05281471Phase 3 · recruiting Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096054Phase 1 · completed A Phase I Trial of LY3143921 Hydrate in Solid Tumours · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06188520Phase 1/Phase 2 · recruiting A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05579366Phase 1/Phase 2 · recruiting Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01883297Phase 1 · active not recruiting "Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05005403Phase 1 · recruiting Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07503808Phase 1 · recruiting A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05027828recruiting CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432594Phase 2 · not yet recruiting Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07269574not yet recruiting Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07268469NA · not yet recruiting Minimal Residual Disease in Solid Malignancies · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05512208Phase 2 · recruiting A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06976892Phase 1 · recruiting Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03268382Phase 2 · completed p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246 · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084195NA · recruiting Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787170completed Prediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06777082recruiting Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05329545Phase 3 · terminated Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05062174withdrawn Breast Cancer BRCA1 Carriers: a Pilot Study · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03123211no longer available Expanded Access to Veliparib · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05188781completed Pembrolizumab and Anlotinib in the Treatment of High-Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05146505unknown miRNAs in High Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04261465Phase 2 · unknown NUVOLA TRIAL Open-label Multicentre Study · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02307240Phase 1 · completed Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01853306Phase 1 · completed A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors · condition mapped ONTOLOGY_EXACT · 28 trials mapped (17 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |